Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Barber Daniel (CIK 1742266) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-16). Recent activity: Sell AQST (25,000 shares), Buy AQST (91,743 shares), Sell AQST (25,000 shares), Sell AQST (4,631 shares), Sell AQST (20,369 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-16 | Aquestive Therapeutics, Inc. (AQST) | President and CEO | Sell | 25,000 | $120,487 |
| 2026-09-09 | Aquestive Therapeutics, Inc. (AQST) | President and CEO | Buy | 91,743 | $88,073 |
| 2026-08-18 | Aquestive Therapeutics, Inc. (AQST) | President and CEO | Sell | 25,000 | $107,168 |
| 2026-07-17 | Aquestive Therapeutics, Inc. (AQST) | President and CEO | Sell | 4,631 | $18,683 |
| 2026-07-17 | Aquestive Therapeutics, Inc. (AQST) | President and CEO | Sell | 20,369 | $81,509 |
| 2026-06-16 | Aquestive Therapeutics, Inc. (AQST) | President and CEO | Sell | 25,000 | $104,000 |
| 2026-05-18 | Aquestive Therapeutics, Inc. (AQST) | President and CEO | Sell | 8,257 | $35,423 |
| 2026-05-07 | Aquestive Therapeutics, Inc. (AQST) | President and CEO | Sell | 335,922 | $1.4M |
| 2026-03-11 | Aquestive Therapeutics, Inc. (AQST) | President and CEO | Buy | 262,000 | $0 |
| 2026-03-11 | Aquestive Therapeutics, Inc. (AQST) | President and CEO | Sell | 180,677 | $753,423 |
| 2025-09-29 | Aquestive Therapeutics, Inc. (AQST) | President and CEO | Sell | 91,343 | $550,798 |
| 2025-09-22 | Aquestive Therapeutics, Inc. (AQST) | President and CEO | Sell | 400 | $2,400 |
Source: SEC Form 4 filings · as of 2026-09-16